RS BioTherapeutics Promotes Michelle L. Shuffett, MD to

RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer. ...

Related Keywords

United States ,David Gutierrez ,Michellel Shuffett ,Dean Hart ,Los Angeles ,Therapeutic Expert Council ,Research Collaboration Agreement ,Boehringer Ingelheim ,Everyday Health ,Dresner Corporate Services ,London School Of Economics ,Million Ways Foundation ,Sea Sprite International Ltd ,University Of Kentucky ,Synapse Medical Communications ,Scientific Affairs ,Chief Medical ,Chief Medical Officer ,Chief Executive Officer ,Idiopathic Pulmonary Fibrosis ,Chronic Pulmonary Obstructive Disease ,Senior Vice President ,Hospital Los ,London School ,Healthcare Economics ,Columbia Care ,Sea Sprite International ,Ways Foundation ,Chronic Obstructive Lung Disease ,Investigational New Drug Application ,Rs Biotherapeutics ,Healthcare ,Pharmaceuticals ,Herapeutics ,Pulmonary ,Pulmonary Inflammation ,